Accepta
 
 
 

Accepta Avian Influenza Test Kit

Accepta Product Bulletin

 

Accepta Test Kit for Influenza A & B

Accepta’s innovative influenza test kit is an immunochromatographic test for the presence of both influenza A (including influenza A H5N1, Avian Influenza) and influenza B virus. The kit can be used for the detection of influenza in swabs or nasopharyngeal secretions (washings or aspirates).

Benefits:

    • Fast – obtain results in 15 minutes.
    • Accurate, easy to interpret results.
    • Simple to use.
    • Cost effective.
    • Single sample analysis.
    • Each kit is self contained, with nothing else required to perform the test.

How to use Accepta's Test Kit

Test Data

Influenza A (side A)
Influnenza B (side B)

Performance compared to commercially available rapid test (on 237 samples)

Specificity: 88%* PPV:78%*
Sensitivity: 99% NPV:99%

*Amongst the 19 samples detected positive with Accepta A+B R-Kit and negative with the commercially available rapid test, 14 have been confirmed positive with RT-PCR

Performance compared to cell culture (on 255 samples)

Specificity: 100% PPV: 100%
Sensitivity: 72.2% NPV:98%

Performance compared to molecular amplification by RT-PCR (on 237 samples)

Specificity: 93% PPV: 94%
Sensitivity: 51% NPV:45%

 
Detectability Level
3,125 106 vp/mL 1,25 107 vp/mL

Influenza A+B - Background

Influenza is a highly contagious viral infection of the upper respiratory tract that is characterised by the antigen variability, the seasonality and the impact on the general population.

Of the two main (A and B) types of influenza viruses, Influenza A subtypes are differentiated by antigen variability of the surface glycoproteins hemagglutinin (H, 15 subtypes) and neuraminidase (N, 9 subtypes). Influenza A is the most prevalent and is associated with the most serious epidemics, its subtypes are classified by H and N antigen types. H1N1, H2N2, H3N2 and H5N1 are the primary influenza A subtypes known to have caused disease in humans since 1918.

Influenza B virus usually causes a minor illness, but it does have the potential to cause more severe disease in older persons. The inability to provide lasting protection to humans against influenza B virus infection is due, in part, to antigenic drifts to the viral surface glycoprotein, haemagglutinin (HA).

Multichromatography (2 sided nitrocellulose laminate)

Test Availability

Description Code No. Tests Storage
Accepta A+B R-Kit Accepta RK100 25 tests per kit Between 4 and 37°C
Accepta A+B U-Kit Accepta UK100 10 tests per kit Between 4 and 37°C


Additional Information

For additional information please contact Accepta on +44 (0) 161 240 2100 or email sales@accepta.com.

 

 

 

*****************************

Please recommend Accepta's newsletter to a friend

Thank you

 

 

Newsletter Back Issues - for back issues of Accepta's newsletter please visit our newsletter archive.

 

 

How to Unsubscribe - you can unsubscribe from this newsletter at any time by e-mailing us at subscribe@accepta.com, inserting the word 'unsubscribe' in the message subject line and sending.

 

 

©2006 Accepta